Are screening and surveillance for Barrett's oesophagus really worthwhile?
P Sharma, EI Sidorenko - Gut, 2005 - gut.bmj.com
Oesophageal adenocarcinoma has a low incidence and still remains an uncommon cancer;
however, it has been on the rise over the past 20 years. Barrett's oesophagus, a …
however, it has been on the rise over the past 20 years. Barrett's oesophagus, a …
Barrett's oesophagus: epidemiology, cancer risk and implications for management
PJF De Jonge, M van Blankenstein, WM Grady… - Gut, 2014 - gut.bmj.com
Although endoscopic surveillance of patients with Barrett's oesophagus has been widely
implemented, its effectiveness is debateable. The recently reported low annual oesophageal …
implemented, its effectiveness is debateable. The recently reported low annual oesophageal …
Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus
JH Rubenstein, AP Thrift - Best practice & research Clinical …, 2015 - Elsevier
Screening for Barrett's oesophagus is an attractive notion due to the rising incidence of
oesophageal adenocarcinoma, the relative ease of acquiring tissue from the oesophagus …
oesophageal adenocarcinoma, the relative ease of acquiring tissue from the oesophagus …
The rationale for screening and surveillance of Barrett's metaplasia
S Wani, P Sharma - Best Practice & Research Clinical Gastroenterology, 2006 - Elsevier
Oesophageal adenocarcinoma is a rare cancer; however, it is the most rapidly increasing
cancer in the western world. Barrett's oesophagus is the only recognised precursor and is …
cancer in the western world. Barrett's oesophagus is the only recognised precursor and is …
Screening and surveillance for Barrett's esophagus—an unresolved dilemma
SJ Spechler - Nature Clinical Practice Gastroenterology & …, 2007 - nature.com
The rising incidence of esophageal adenocarcinoma has stimulated interest in screening for
Barrett's esophagus, but there is no proof that screening decreases esophageal cancer …
Barrett's esophagus, but there is no proof that screening decreases esophageal cancer …
[HTML][HTML] Endoscopic screening and surveillance for Barrett's esophagus–clinical implications
There is now a clear causal relationship between symptomatic gastroesophageal reflux and
esophageal adenocarcinoma (Lagergren et al, 1999). The risk factor is now identified as …
esophageal adenocarcinoma (Lagergren et al, 1999). The risk factor is now identified as …
Screening and surveillance of Barrett's oesophagus: what is a cost‐effective framework?
SJ Spechler, H Barr - Alimentary Pharmacology & Therapeutics, 2004 - Wiley Online Library
There is a strong association between symptomatic gastro‐oesophageal reflux and
oesophageal adenocarcinoma. With this in mind, the American College of Gastroenterology …
oesophageal adenocarcinoma. With this in mind, the American College of Gastroenterology …
[HTML][HTML] Barrett's oesophagus: current controversies
C Amadi, P Gatenby - World Journal of Gastroenterology, 2017 - ncbi.nlm.nih.gov
Oesophageal adenocarcinoma is rapidly increasing in Western countries. This tumour
frequently presents late in its course with metastatic disease and has a very poor prognosis …
frequently presents late in its course with metastatic disease and has a very poor prognosis …
A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance
S Gudlaugsdottir, M van Blankenstein… - European journal of …, 2001 - journals.lww.com
Background Endoscopic cancer surveillance has been advocated for patients with Barrett's
oesophagus. However, only a small minority of patients dies from adenocarcinoma in …
oesophagus. However, only a small minority of patients dies from adenocarcinoma in …
Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
R Quera, K O'Sullivan, EMM Quigley - Endoscopy, 2006 - thieme-connect.com
Results: Four patients in this high-risk group developed adenocarcinoma during
surveillance, with survival rates of 78.9%(95% CI 64.9%-88.5%) at 2 years and 78.6%(95 …
surveillance, with survival rates of 78.9%(95% CI 64.9%-88.5%) at 2 years and 78.6%(95 …